RANKL Inhibition by Osteoprotegerin Prevents Bone Loss Without Affecting Local or Systemic Inflammation Parameters in Two Rat Arthritis Models: Comparison With Anti-TNFα or Anti-Il-1 Therapies

Arthritis Research and Therapy - United Kingdom
doi 10.1186/ar2879

Related search